There is increasing evidence that inflammation plays a role in progression and
destabilization of atherosclerotic plaque. FDG-PET can visualize activated metabolic activity
of inflammatory cells. It is possible that FDG-PET can detect atherosclerotic plaque
inflammation and that FDG-PET can monitor the effect of pioglitazone on plaque inflammation.